Evaluation and treatment of chronic hepatitis C infection

Primary Care - Clinics in Office Practice

Volumn 23, Issue 3, 1996, Pages 535-549

  Neiblum, D R ^a   Boynton, R F ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

AUTOIMMUNE HEPATITIS; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; HEPATITIS B; HEPATITIS C; HOMOSEXUALITY; HUMAN; IMMUNOTHERAPY; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LIVER TRANSPLANTATION; OCCUPATIONAL HAZARD; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEXUAL BEHAVIOR; UNITED STATES; VIRUS CHARACTERIZATION;

EID: 0029836396     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-4543(05)70346-8     Document Type: Article

References (65)

1. H.J. Alter Chronic consequences of non-A, non-B hepatitis L.B. Seeff J.G. Lewis Current Perspectives in Hepatology: Festschrift for Hyman J. Zimmerman, MD 1989 Plenum Publishing New York 83 97
2. H.J. Alter New kit on the block: Evaluation of second-generation assays for detection of antibody to the hepatitis C virus Hepatology 15 1992 350 353
3. H.J. Alter H.S. Margolis K. Krawczynski Clinical outcome and risk factors associated with hepatitis C in the United States;obabstract;cb Hepatology 10 1989 581
4. H.J. Alter H.S. Margolis K. Krawczynski The natural history of community acquired hepatitis C in the United States N Engl J Med 327 1993 1899 1905
5. M.F. Alter S.G. Hadler F.N. Judson Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection JAMA 264 1990 2231 2235
6. S. Baron S.K. Tyring W.R. Fleishchmann Jr The interferons: Mechanisms of action and clinical applications JAMA 266 1991 1375 1383
7. M. Berman H.J. Alter K.G. Ishak The chronic sequelae of non-A, non-B hepatitis Ann Intern Med 91 1979 1 6
8. S. Brillanti C. Masci S. Siringo Serological and histological aspects of hepatitis C virus infection in alcoholic patients J Hepatol 13 1991 347 350
9. X. Causse H. Godinot M. Chevallier Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis Gastroenterology 101 1991 497 502
10. R.W.G. Chapman B.A.M. Arborgh J.M. Rhodes Primary sclerosing cholangitis: A review of its clinical features, cholangiography and hepatic histology Gut 21 1980 870 877
11. Q. Choo G. Kuo A.J. Weiner Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome Science 244 1989 359 364
12. G.L. Davis Interferon treatment of chronic hepatitis C Am J Med 96 1994 41S 46S
13. G.L. Davis L.A. Balart E.R. Schiff Treatment of chronic hepatitis C with recombinant interferon alfa: A multicenter randomized, controlled trial N Engl J Med 321 1989 1501 1506
14. G.L. Davis K. Lindsay J. Albrecht Predictors of response to recombinant alpha interferon treatment in patients with chronic hepatitis C;obabstract;cb Hepatology 12 1990 905
15. J.G. Donahue A. Munoz P.M. Ness The declining risk of post-transfusion hepatitis C virus infection N Engl J Med 327 1992 369 373
16. F.J. Dudley M.J. O'Shea A. Ajdukiewicz Serum autoantibodies and immunoglobulins in hepatitis-associated antigen (HAA)-positive and negative liver disease Gut 14 1973 360 364
17. P. Farci H.J. Alter D. Wong A long-term study of hepatitis C virus replication in non-A, non-B hepatitis N Engl J Med 325 1991 98 104
18. G.C. Farrell R. Lin S. Coverdale Prediction of response to interferon in patients with chronic active hepatitis C and evidence that this improves hepatic metabolic function Gastroenterologia Japonica 26 suppl 3 1991 243 246
19. S.M. Feinstone A.Z. Kapikian R.H. Purcell Transfusion-associated hepatitis not due to viral hepatitis type A or B N Engl J Med 292 1975 767 770
20. L.M. Fletcher I. Kwoh-Gain E.E. Powell Markers of chronic alcohol ingestion in patients with nonalcoholic steatohepatitis: An aid to diagnosis Hepatology 13 1991 455 459
21. J.H. Gilliam III K.R. Geisinger J.E. Richter Primary hepatocellular carcinoma after chronic non-A, non-B post-transfusion hepatitis Ann Intern Med 101 1984 794 795
22. M. Giovanni A. Tagger M.L. Ribero Maternal-infant transmission of hepatitis C virus and HIV infections: A possible interaction Lancet 335 1990 1166
23. S.C. Gumber S. Chopra Hepatitis C: A multifaceted disease Ann Intern Med 123 1995 615 620
24. J.H. Hoofnagle K.D. Mullen D.B. Jones Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon: A preliminary report N Engl J Med 315 1986 1575 1578
25. L.J. Jeffers F. Hasan M. De Medina Prevalence of antibodies to hepatitis C virus among patients with cryptogenic chronic hepatitis and cirrhosis Hepatology 15 1992 187 190
26. P.J. Johnson I.G. McFarlane P. Williams Azathioprine for long-term maintenance of remission in autoimmune hepatitis N Engl J Med 333 1995 958 963
27. A.P. Kirk S. Jain S. Pocock Late results of Royal Free Hospital controlled trial of prednisolone therapy in hepatitis B surface antigen-negative chronic active hepatitis Gut 21 1980 78 83
28. K. Kiyosawa T. Sodeyama E. Tanaka Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus Hepatology 12 1990 671 675
29. R.L. Koretz O. Stone M. Mousa Non-A, non-B posttransfusion hepatitis—A decade later Gastroenterology 88 1985 1251 1254
30. J.Y.N. Lau G.L. Davis J. Kniffen Significance of serum Hepatitis C virus RNA levels in chronic hepatitis Lancet 341 1993 1501 1504
31. W.C. Maddrey Alcoholic hepatitis: Pathogenesis and approaches to treatment Scand J Gastroenterol 175 1990 118 130
32. W.C. Maddrey Chronic hepatitis Dis Mon 39 1993 65 125
33. W.C. Maddrey Drug-related acute and chronic hepatitis Clinics in Gastroenterology 9 1980 213 224
34. W.C. Maddrey J.D. Boitnott Severe hepatitis from methyldopa Gastroenterology 68 1975 351 360
35. P. Marcellin N. Boyer E. Giostra Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: A multicenter randomized controlled trial from France Hepatology 13 1991 393 397
36. P. Marcellin M. Pouteau N. Boyer Absence of efficacy of an increasing dosage schedule on the response rate during and after recombinant alpha interferon therapy in chronic hepatitis C;obabstract;cb Hepatology 14 1991 71A
37. K.H. Meyer zum Buschenfelde A.W. Lohse M. Manns Autoimmunity and liver disease Hepatology 12 1990 354 363
38. P.R. Mills T.H. Pennington P. Kay Hepatitis B's antibody in alcoholic cirrhosis J Clin Pathol 32 1979 778 782
39. S.I. Okada Y. Akahane H. Suzuki The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients Hepatology 16 1992 619 624
40. R.P. Perrillo Interferon in the management of chronic hepatitis B Dig Dis Sci 38 1993 577 593
41. E.E. Powell G.E. Cooksley R. Hanson The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years Hepatology 11 1990 74 80
42. T. Poynard P. Bedossa M. Chevallier A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis N Engl J Med 332 1995 1457 1462
43. A.M. Prince B. Brotman G.F. Grady Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis-B virus Lancet 2 1974 241 246
44. J.J. Rakela A.G. Redeker Chronic liver disease after acute non-A, non-B viral hepatitis Gastroenterology 77 1979 1200 1202
45. F. Regenstein New approaches to the treatment of chronic viral hepatitis B and C Am J Med 96 suppl 1A 1994 47S 51S
46. P.F. Renault J.H. Hoofnagle Y. Park Psychiatric complications of long-term alpha interferon therapy Arch Intern Med 147 1987 1577 1580
47. T.B. Reynolds R.L. Peters S. Yamada Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin N Engl J Med 285 1971 813 820
48. J.S. Rodman D.J. Deutsch S.I. Gutman Methydopa hepatitis: A report of six cases and review of the literature Am J Med 60 1976 941 948
49. R.A. Rubin M. Falestiny P.F. Malet Chronic hepatitis C: Advances in diagnostic testing and therapy Arch Intern Med 154 1994 387 392
50. P.J. Scheuer P. Ashrafzadeh S. Sherlock The pathology of hepatitis C Hepatology 15 1992 567 571
51. M.L. Schilsky I.H. Scheinberg I. Sternlieb Prognosis of Wilsonian chronic active hepatitis Gastroenterology 100 1991 762 767
52. J. Scott J.L. Gollan S. Samourian Wilson's disease, presenting as chronic active hepatitis Gastroenterology 74 1978 645 651
53. L.B. Seeff Drug-induced chronic liver disease, with emphasis on chronic active hepatitis Semin Liver Dis 1 1981 104 115
54. L.B. Seeff Z. Buskell-Bales E.C. Wright Long-term mortality after transfusion-associated non-A, non-B hepatitis N Engl J Med 327 1992 1906 1911
55. J.R. Sharp K.G. Ishak H.J. Zimmerman Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin Ann Intern Med 92 1980 14 19
56. M. Shindo A.M. DiBisceglie J.H. Hoofnagle Long-term follow-up of patients with chronic hepatitis C treated with interferon Hepatology 15 1992 1013 1016
57. R.G. Simonetti C. Camma F. Fiorello Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis Ann Intern Med 116 1992 97 102
58. A. Stromberg B. Wengle Chronic active hepatitis induced by nitrofurantoin BMJ 186 1976 174 175
59. F. Tine S. Magrin A. Craxi Interferon for non-A, non-B chronic hepatitis: A meta-analysis of randomized clinical trials J Hepatol 13 1991 192 199
60. P.J. Toghill P.G. Smith P. Benton Methyldopa liver damage BMJ 3 1974 545 548
61. J.M. Walshe Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride Lancet 1 1982 643 647
62. J.M. Walshe Wilson's disease and chronic active hepatitis Lancet 1 1977 605 606
63. J.R. Wood A.J. Czaja S.J. Beaver Frequency and significance of antibody to double-stranded DNA in chronic active hepatitis Hepatology 6 1986 976 980
64. T.L. Wright E. Donegan H.H. Hsu Recurrent and acquired hepatitis C viral infection in liver transplant recipients Gastroenterology 103 1992 317 322
65. N. Yoshiyuki M. Akihiro T. Eiji Detection of chronic hepatitis C virus infection by four diagnostic systems: First-generation and second-generation enzyme-linked immunosorbent assay, second-generation recombinant immunoblot assay and nested polymerase chain reaction analysis Hepatology 16 1992 300 305